These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17954610)

  • 41. Telomere sister chromatid exchange in telomerase deficient murine cells.
    Wang Y; Giannone RJ; Liu Y
    Cell Cycle; 2005 Oct; 4(10):1320-2. PubMed ID: 16131840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres.
    Wang Y; Erdmann N; Giannone RJ; Wu J; Gomez M; Liu Y
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10256-60. PubMed ID: 16000404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hairy breakup.
    Beckman M
    Sci Aging Knowledge Environ; 2005 Aug; 2005(33):nf66. PubMed ID: 16107659
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of U-STELA for Accurate Measurement of Extremely Short Telomeres.
    Serakinci N; Cagsin H; Mavis M
    Methods Mol Biol; 2019; 2045():217-224. PubMed ID: 29542055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Telomeres and telomerase in normal and cancer stem cells.
    Shay JW; Wright WE
    FEBS Lett; 2010 Sep; 584(17):3819-25. PubMed ID: 20493857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telomeres, telomerase, and hematopoietic stem cell biology.
    Greenwood MJ; Lansdorp PM
    Arch Med Res; 2003; 34(6):489-95. PubMed ID: 14734088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Telomere dynamics in Fancg-deficient mouse and human cells.
    Franco S; van de Vrugt HJ; Fernández P; Aracil M; Arwert F; Blasco MA
    Blood; 2004 Dec; 104(13):3927-35. PubMed ID: 15319283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
    Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
    Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation.
    Choudhury AR; Ju Z; Djojosubroto MW; Schienke A; Lechel A; Schaetzlein S; Jiang H; Stepczynska A; Wang C; Buer J; Lee HW; von Zglinicki T; Ganser A; Schirmacher P; Nakauchi H; Rudolph KL
    Nat Genet; 2007 Jan; 39(1):99-105. PubMed ID: 17143283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endogenous Telomerase Reverse Transcriptase N-Terminal Tagging Affects Human Telomerase Function at Telomeres In Vivo.
    Chiba K; Vogan JM; Wu RA; Gill MS; Zhang X; Collins K; Hockemeyer D
    Mol Cell Biol; 2017 Feb; 37(3):. PubMed ID: 27872149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.
    He H; Wang Y; Guo X; Ramchandani S; Ma J; Shen MF; Garcia DA; Deng Y; Multani AS; You MJ; Chang S
    Mol Cell Biol; 2009 Jan; 29(1):229-40. PubMed ID: 18936156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telomeres and telomerase in adult stem cells and pluripotent embryonic stem cells.
    Marión RM; Blasco MA
    Adv Exp Med Biol; 2010; 695():118-31. PubMed ID: 21222203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Telomere length homeostasis.
    Hug N; Lingner J
    Chromosoma; 2006 Dec; 115(6):413-25. PubMed ID: 16741708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells.
    Marion RM; Strati K; Li H; Tejera A; Schoeftner S; Ortega S; Serrano M; Blasco MA
    Cell Stem Cell; 2009 Feb; 4(2):141-54. PubMed ID: 19200803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Telomerase regulation and stem cell behaviour.
    Flores I; Benetti R; Blasco MA
    Curr Opin Cell Biol; 2006 Jun; 18(3):254-60. PubMed ID: 16617011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
    Engelhardt M; Martens UM
    Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of the TRF2 telomeric protein in cancer and ageing.
    Muñoz P; Blanco R; Blasco MA
    Cell Cycle; 2006 Apr; 5(7):718-21. PubMed ID: 16582635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PCB153 reduces telomerase activity and telomere length in immortalized human skin keratinocytes (HaCaT) but not in human foreskin keratinocytes (NFK).
    Senthilkumar PK; Robertson LW; Ludewig G
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):115-23. PubMed ID: 22210444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telomere length homeostasis requires that telomerase levels are limiting.
    Cristofari G; Lingner J
    EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.